Brief: AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
April 30 (Reuters) - AC Immune SA ACIU.O: AC IMMUNE Q1 OPERATING EXPENSES CHF -20.36 MILLION AC IMMUNE Q1 EPS CHF -0.19 AC IMMUNE Q1 PRETAX PROFIT CHF -19.029 MILLION AC IMMUNE Q1 NET INCOME CHF -19.029 MILLION AC IMMUNE Q1 OPERATING INCOME CHF -19.37 MILLION Source text: ID:nGNX9VYnXH Further company coverage: ACIU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health